These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 16721044

  • 1. Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-gamma and EGF.
    Reimer D, Sadr S, Wiedemair A, Concin N, Hofstetter G, Marth C, Zeimet AG.
    Cancer Biol Ther; 2006 Jul; 5(7):771-6. PubMed ID: 16721044
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
    Reimer D, Sadr S, Wiedemair A, Stadlmann S, Concin N, Hofstetter G, Müller-Holzner E, Marth C, Zeimet AG.
    Clin Cancer Res; 2007 Jan 01; 13(1):144-51. PubMed ID: 17200349
    [Abstract] [Full Text] [Related]

  • 3. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH.
    Oncogene; 2008 Jan 10; 27(3):366-77. PubMed ID: 17637753
    [Abstract] [Full Text] [Related]

  • 4. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ, Dicker AJ, Dahler AL, Saunders NA.
    J Invest Dermatol; 1997 Aug 10; 109(2):187-93. PubMed ID: 9242506
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R, Cheng E, Smicun Y, Germino J.
    J Exp Med; 2000 Mar 20; 191(6):1005-16. PubMed ID: 10727462
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
    Vaishnav YN, Pant V.
    DNA Cell Biol; 1999 Dec 20; 18(12):911-22. PubMed ID: 10619603
    [Abstract] [Full Text] [Related]

  • 9. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA.
    Oncogene; 1998 Aug 20; 17(7):867-76. PubMed ID: 9780003
    [Abstract] [Full Text] [Related]

  • 10. Prognostic values of E2F mRNA expression in human gastric cancer.
    Manicum T, Ni F, Ye Y, Fan X, Chen BC.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30487158
    [Abstract] [Full Text] [Related]

  • 11. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
    Reimer D, Hubalek M, Riedle S, Skvortsov S, Erdel M, Concin N, Fiegl H, Müller-Holzner E, Marth C, Illmensee K, Altevogt P, Zeimet AG.
    Cancer Res; 2010 Jun 01; 70(11):4613-23. PubMed ID: 20460525
    [Abstract] [Full Text] [Related]

  • 12. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM, Gall AL, Zheng N, Pavletich NP.
    Cell; 2005 Dec 16; 123(6):1093-106. PubMed ID: 16360038
    [Abstract] [Full Text] [Related]

  • 13. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN.
    Oncogene; 1997 Jul 10; 15(2):143-57. PubMed ID: 9244350
    [Abstract] [Full Text] [Related]

  • 14. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y.
    Kokubyo Gakkai Zasshi; 1998 Jun 10; 65(2):172-88. PubMed ID: 9711036
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
    Lu Z, Luo RZ, Peng H, Rosen DG, Atkinson EN, Warneke C, Huang M, Nishmoto A, Liu J, Liao WS, Yu Y, Bast RC.
    Clin Cancer Res; 2006 Apr 15; 12(8):2404-13. PubMed ID: 16638845
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M.
    Oncogene; 1999 Mar 18; 18(11):2003-14. PubMed ID: 10208422
    [Abstract] [Full Text] [Related]

  • 17. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
    Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A, Müller-Werdan U, Werdan K, Braun T.
    Circ Res; 2005 Mar 18; 96(5):509-17. PubMed ID: 15718499
    [Abstract] [Full Text] [Related]

  • 18. [Differences in human and rat FSH receptors promote activity as a result of the transcriptional factors: E2F1, E2F4 and E2F5 overexpression].
    Putowski L, Gasior W, Gogacz M, Gagała J, Jakowicki JA.
    Ginekol Pol; 2001 Dec 18; 72(12A):1560-6. PubMed ID: 11883315
    [Abstract] [Full Text] [Related]

  • 19. E2F-4, a new member of the E2F transcription factor family, interacts with p107.
    Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM.
    Genes Dev; 1994 Nov 15; 8(22):2665-79. PubMed ID: 7958924
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.
    Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC.
    Cancer Res; 1997 Nov 01; 57(21):4722-6. PubMed ID: 9354430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.